Quantitative risk-benefit analysis of natalizumab

R. G. Holloway, J. P. Thompson, K. Noyes, R. R. Dorsey, S. R. Schwid

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1791-1792
Number of pages2
JournalNeurology
Volume72
Issue number20
DOIs
StatePublished - May 19 2009

ASJC Scopus subject areas

  • Clinical Neurology

Cite this